STEGLUJAN cpr pell 5mg/100mg 98 pce
7680665780047
CH-66578
A10BD24
07.06.2.
Reimbursement limitations:
STEGLUJAN
Pour améliorer la glycémie chez les patients adultes présentant un diabète de type 2:
- …
1 / 3
google
Details
- Product number
- 6657802
- CPT
- -
- Packaging group
- 98
- Unit
- Tablette(n)
- Composition
- ertugliflozinum 5 mg ut ertugliflozini l-pidolas 6.477 mg, sitagliptinum 100 mg ut sitagliptini phosphas monohydricus 128.9 mg, E 310, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, Überzug: hydroxypropylcellulosum, hypromellosum, E 171, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), cera carnauba, pro compresso obducto, natrium 1.57 mg.
Articles (1)
Steglujan 5 mg /100 mg, Filmtabletten
Filmtabletten
98
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
6.477 MG | Substance | WIZUS |
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
128.9 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.57 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 238.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2019
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 66578
- Drug name
- Steglujan, Filmtabletten
- Galenic form
- FILM
- ATC Code
- A10BD24
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/10/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- STEGLUJAN 5 mg /100 mg cpr pellic 5 mg 98 pce
- Description (DE)
- STEGLUJAN 5 mg /100 mg Filmtabl 5 mg 98 Stk
- Market launch
- 18/10/2018
- Narcotic (BTM)
- No